ZYME Competitors & Alternatives
Compare Zymeworks Inc. Common Stock with similar stocks in the same industry
Biotechnology
ZYME
Main Stock$24.82
Tradestie Score
56
Market Cap
$1.28B
Revenue Growth
-0.9%
Analyst Upside
+58.5%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$18.15
|
$2.02B | 54.1 | 58 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.50
|
$2.01B | - | 52 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$38.24
|
$1.97B | - | 61 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.71
|
$1.92B | - | 55 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$103.38
|
$1.92B | - | 58 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$76.40
|
$1.90B | 458.4 | 58 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$42.72
|
$1.84B | - | 57 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$33.72
|
$1.81B | - | 63 | Compare |
|
MPLT
MPLT
|
$37.98
|
$1.78B | - | 63 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$6.80
|
$1.78B | - | 57 | Compare |
More ZYME Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry